As of November 15, 2026, Charles River Laboratories International Inc is a publicly traded company (NYSE: CRL); its largest reported holder is Fidelity (FMR), with 12.4% on Schedule 13G/A of November 5, 2026, then Vanguard (7.38%). The largest insider holding is James C. Foster, a director, with 233,410 shares (0.49% of shares outstanding), per Form 4 of October 26, 2026 (Schedule 13G/A, November 5, 2026).
Is this your company?
About to sign with, pay or invest in Charles River Laboratories International Inc? See the free Snapshot first.
Free to see. No signup.
Is Charles River Laboratories International Inc a real, registered company?
- Charles River Laboratories International Inc files with the SEC under CIK 1100682 (its SEC filings).
- Its shares are listed under the ticker CRL on NYSE (SEC company record).
- business address in Wilmington, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Charles River Laboratories International Inc in our court records and SEC 8-K records (as of 2026-11-15).
- Leadership changes: the latest reported is James C. Foster, Chief Executive Officer (Form 8-K filed 2026-01-09). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-11-05).
Who are Charles River Laboratories International Inc's owners and officers?
Charles River Laboratories International Inc: business address in Wilmington, Massachusetts; industry Services-Commercial Physical & Biological Research (Schedule 13G/A, 2026-11-10).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-10 | Invesco LTD. | 3.9% |
| Schedule 13G/A, 2026-11-05 | Fmr LLC | 12.4% |
| Schedule 13G/A, 2026-09-08 | Fmr LLC | 10.2% |
| Schedule 13G, 2026-08-13 | Invesco LTD. | 6.2% |
| Schedule 13G/A, 2026-08-06 | Fmr LLC | 8.8% |
| Schedule 13G, 2026-05-06 | Fmr LLC | 7% |
| Schedule 13G/A, 2026-05-06 | Invesco LTD. | 4.9% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 7.38% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-12 | Invesco LTD. | 5.5% |
| Schedule 13G/A, 2026-02-10 | Wellington Management Group LLP | 3.6% |
| Schedule 13G/A, 2025-11-14 | Nomura Holdings Inc | 1.6% |
Questions about who owns Charles River Laboratories International Inc
Who owns Charles River Laboratories International Inc?
On this page, 2 holders' latest ownership filings report 5% or more of Charles River Laboratories International Inc: Fmr LLC (12.4%, Schedule 13G/A, filed 2026-11-05) and Vanguard Capital Management (7.38%, Schedule 13G, filed 2026-04-29).
Who are the largest shareholders of Charles River Laboratories International Inc?
By the share each holder's latest filing reports, the largest holders of Charles River Laboratories International Inc on this page are Fmr LLC (12.4%) and Vanguard Capital Management (7.38%).
When did Fmr LLC buy into Charles River Laboratories International Inc?
The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G, filed 2026-05-06, reporting 7%; its latest, Schedule 13G/A filed 2026-11-05, reports 12.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Charles River Laboratories International Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Charles River Laboratories International Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Charles River Laboratories International Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-01-09 | James C. Foster | Chief Executive Officer | appointed | 2026-05-05 |
Which insiders own Charles River Laboratories International Inc shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 233,410 shares (0.49% of shares outstanding), 31,596 held directly and 201,814 indirectly (Form 4, 2026-10-26).
- , the chief executive and a director: 79,288 shares (0.17% of shares outstanding), 35,485 held directly and 43,803 indirectly (Form 4, 2026-08-20).
- , the cevp and disc: 42,997 shares (0.09% of shares outstanding), 4,807 held directly and 38,190 indirectly (Form 4, 2026-10-23).
- , a director: 31,393 shares (0.07% of shares outstanding) (Form 4, 2024-11-12).
- , the executive vice president and corp strategy: 31,041 shares (0.06% of shares outstanding) (Form 4, 2026-08-11).
Shares outstanding: 47,917,467 as of 2026-10-24, from the company's latest SEC cover page.
How much has Charles River Laboratories International Inc raised?
No fundraising or offering filing from Charles River Laboratories International Inc is on file with us.
Keep reading
More on Charles River Laboratories International Inc and the records around it.
Charles River Laboratories International Inc elsewhere on the record
- Leadership changes May 2026
Companies that share a holder
- NOMURA HOLDINGS INC also filed stake reports on 21 other companies: DESTINATION XL GROUP, INC. (Aug 2026), Integer Holdings Corp (Aug 2026), Torrid Holdings Inc. (Aug 2026)
- Invesco Ltd. also filed stake reports on 93 other companies: Alignment Healthcare Inc (Nov 2026), ArcBest Corp (Nov 2026), Canaan Inc (Nov 2026)
- Wellington Management Group LLP also filed stake reports on 240 other companies: Hub Group, Inc. (Oct 2026), Latham Group, Inc. (Oct 2026), Redwood Trust, Inc. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/charles-river-laboratories-international